key: cord-0035248-za2rbos2 authors: Wang, Lemin title: Venous Thrombus date: 2018-02-27 journal: The Origin and Onset of Thrombus Disease DOI: 10.1007/978-981-10-7344-1_1 sha: 1da53aa4fca7bc37bbefd7c8799bd0e2ccbcd100 doc_id: 35248 cord_uid: za2rbos2 Venous thromboembolism (VTE) includes pulmonary thromboembolism (PE) and deep venous thrombosis (DVT). Both belonging to thrombus, acute arterial thrombus is white thrombus, while acute venous thrombus is red thrombus. What does the pathological difference mean? Venous thrombosis can autolyze, while arterial thrombosis cannot. For VTE patients, oral anticoagulants are usually recommended for 3, 6, or 12 months and occasionally lifelong, but the course cannot be determined. Furthermore, even with standard anticoagulation therapy and INR, some patients still develop chronic thromboembolic pulmonary hypertension (CTEPH). Thus, the physicians are extremely puzzled about anticoagulant usage. Proposed risk factors for VTE include advanced age, infection, malignancy, autoimmune disease, surgery, trauma, pregnancy, long trip syndrome, family history, AMI, heart failure, and so on. Relevant risk factors are increasing over time. Risk factors are derived from the summary of evidence-based medicine. Although these factors are found to be associated with venous thrombosis, the intrinsic factors have not been well elucidated. Lemin Wang Venous thromboembolism (VTE) includes pulmonary thromboembolism (PE) and deep venous thrombosis (DVT). Both belonging to thrombus, acute arterial thrombus is white thrombus, while acute venous thrombus is red thrombus. What does the pathological difference mean? Venous thrombosis can autolyze, while arterial thrombosis cannot. For VTE patients, oral anticoagulants are usually recommended for 3, 6, or 12 months and occasionally lifelong, but the course cannot be determined. Furthermore, even with standard anticoagulation therapy and INR, some patients still develop chronic thromboembolic pulmonary hypertension (CTEPH). Thus, the physicians are extremely puzzled about anticoagulant usage. Proposed risk factors for VTE include advanced age, infection, malignancy, autoimmune disease, surgery, trauma, pregnancy, long trip syndrome, family history, AMI, heart failure, and so on. Relevant risk factors are increasing over time. Risk factors are derived from the summary of evidence-based medicine. Although these factors are found to be associated with venous thrombosis, the intrinsic factors have not been well elucidated [1] [2] [3] [4] . Clinically diagnosed VTE is also known as dominant VTE, but the diagnosis of insidious VTE is very difficult, and it is often found at autopsy. DVT of cerebral cortical vein and cerebral venous sinus, acute PE, chronic thromboembolic pulmonary hypertension, hepatic venule occlusion, DVT of mesenteric vein and pelvic vein, postoperative DVT and PE, and lower limb DVT are diagnosed in different departments, and thus VTE is almost a disease faced by clinicians in all departments. Of these DVTs, PE has a high morbidity, high misdiagnosis rate and high mortality and has been an important health problem worldwide [1, 2] . VTE Several thrombi were extracted from the pulmonary artery of PE patients. In acute venous thrombosis, thrombus is microscopically red and is composed of red blood cells, platelets, white blood cells, and plasma proteins under a microscope. The thrombus in acute venous thrombosis is often fragile (Fig. 1.4) . Mass spectrographic analyses showed that the majority of proteins in the acute venous thrombus were fibrinogen; the remaining proteins included serum albumin and cytoskeletal proteins ( Fig. 1.5 ). The reversible combinations between fibrinogen and their ligands theologically explain that acute venous thrombus is easy to autolyze; delayed thrombolysis is effective, and the thrombus is easy to lyse through interventional fragmentation [5] . In acute venous thrombosis, the thrombus is red and is composed of red blood cells, platelets, white blood cells, and fibrinogen. How does fibrinogen bind to blood cells in the thrombosis? MS/MS and bioinformatics analysis of the thrombus from acute PE patients showed that integrin subunits β 1 , β 2 , and β 3 were the core proteins of the thrombus (Figs. 1.6 and 1.7). Integrins are important members in the cell adhesion molecule family and mediate the adhesion between cells and between cells and extracellular matrix (ECM) as well as the bidirectional signal transduction between cells and ECM. Integrins can bind to some ligands related to cell activities and are involved in some physiological and pathological processes, including angiogenesis, invasion and metastasis of cancers, inflammation, wound healing, and coagulation [6] . Integrin is a transmembrane heterodimer composed of subunits α and β at a ratio of 1:1 ( Fig. 1.8) . To date, a total of 18 α subunits and 8 β subunits have been identified, and they can form 24 functional heterodimers, which may be classified into 8 groups (β 1 -β8) on the basis of β subunit. In the same group, the β subunit is identical, but the α subunit is distinct. At rest, the α subunit is covered by the β subunit, and thus the integrin is unable to bind to its ligands. Following activation, the extension of the β subunit exposes the α subunit. The α subunit mainly mediates the specific and reversible binding between integrins and their ligands (Figs. 1.9 and 1.10), and the β subunit dominates the signal transduction and regulation of integrins affinity [7] [8] [9] . The β 1 subunit is mainly found on the lymphocytes and platelets, and its ligands include laminin, collagen, thrombospondin, fibronectin, and VCAM-1. The β 2 subunit is mainly distributed on the neutrophils and monocytes, and its ligands include fibrinogen, ICAM, factor X, and iC3b. The β 3 subunit is mainly observed on the platelets, and its ligands include fibrinogen, fibronectin, vitronectin, vWF, and thrombospondin [10] [11] [12] . The authors reported that a catheter could be used to extract the thrombus from the pulmonary artery of acute PE patients [13] . Immunohistochemistry showed that dark-brown integrin β 1 was expressed on membrane of lymphocytes, but lymphocytes had no expression of laminin, fibronectin, collagen-I, or collagen-II (receptors of integrin β 1 ) ( Fig. 1.11 ). Immunohistochemistry showed that dark-brown integrin β 2 was expressed on the membrane of neutrophils, which bound to fibrinogen, whereas ICAM, factor X, and iC3b were expressed on the membrane of neutrophils ( Fig. 1.12 ). Immunohistochemistry showed that dark-brown integrin β 3 was expressed on platelets, which aggregated to form thrombotic skeleton; these platelets bound to fibrinogen to construct filamentous mesh structure. No expression of fibronectin, vitronectin, or vWF was observed on the platelets ( Fig. 1.13 ). Dark-brown factor Xa was distributed on the filamentous mesh structure, which was composed of fibrin/fibrinogen ( Fig. 1.14) . To prevent PE, different kinds of filters such as vena cava filters were developed 30 years ago and had been applied in clinical practice to block DVT thrombi below the inferior vena cava reflowing to the pulmonary artery by constructing a mesh structure ( Fig. 1.15 left and Fig. 1.16 left) . Pathological examination of the thrombus showed a biofilter similar to the artificial filter ( Fig. 1.15, right) , and the biofilter was full of blood cells ( Fig. 1.16, right) . These findings indicate that biofilter has similar function to artificial filter. The sophisticated body always adjusts to the favorable direction of development and tends to balance stability and continuity between the internal and external environments. Biological venous filter is a result of the body's own regulation. What is the role of the spontaneous venous biological filter? The central thrombus showed filament-like filter structure ( Fig. 1.17a) , which was full of erythrocyte-dominant blood cells ( Fig. 1.17b ). The pathological examination of intestinal cancer showed biofilters in the veins of the caner ( Fig. 1.17c) , and cancer cells were found in the biofilters ( Fig. 1.17d) , suggesting that the biofilter may block the hematogenous metastasis of cancer cells [14] . In acute PE patients (reductions in CD 3 + T cells and CD 8 + T cells), electronic microscopy of peripheral venous blood showed virus-like microorganisms in , which seem to be cells with intracellular infection [15] . In patients with repeated PE/DVT (reductions in CD 3 + T cells and CD 8 + T cells), electronic microscopy of peripheral venous blood showed rod-shaped bacteria-like structures in the cytoplasm of phagocytes ( Fig. 1.20) , which seem to be neutrophils with intracellular infection [16] . The immune system in the human body is the defense system. In simple terms, the immune system functions to expel all the foreign bodies including exogenous pathogenic microorganisms, grafts, foreign bodies in the wound, toxins, senescent cells, and malignant cells. The immune system can be divided into innate and adaptive immunity. Innate immunity is present from birth and is also known as congenital immunity. Innate immune is an evolutionarily ancient defense strategy and is mainly composed of macrophages, granulocytes, NK cells, and complement system. Innate immune can recognize and subsequently clear foreign bodies and then present the information of these foreign bodies to T helper cells in adaptive immune. Adaptive immune is an acquired system during the lifetime of the organism. Immunological memory is a characteristic of adaptive immune and is highly specific to a particular pathogen. Thus, adaptive immune is also known as specific immune system and is composed of T cells and B cells. T helper cells are the core of the immune cells that regulate the cellular immunity and humoral immunity as well as the functions of phagocytes. Under physiological conditions, the alloantigens (pathogenic microorganisms or malignant cells) in the circulation can be effectively and timely recognized and cleared by immune cells. In the vein, cells with intracellular infection and malignant cells cannot be killed and cleared by immune cells, implying that the immune cells lose their function and are unable to maintain the defense. Under such conditions, a new compensatory defense should be initiated. The release of reserved compensatory defense is a basic law for life sustainability. The venous defense is manifested by the formation of venous biofilter, which is full of blood cells in the backflow blood, causing venous thrombosis. This may lead to the progression from compensatory defense in the vein into venous thrombosis. On the other hand, this implies that there are cells with intracellular infection or malignant cells in patients with venous thromboembolic diseases. Infected leukocytes or intravenous malignant cells cannot be timely and effectively killed and cleared, indicating the loss of function of immune cells. This also indicates that the immune system function is changed. Herein, we analyze this phenomenon at the gene and cell levels. Genomics has the characteristics of wholeness, comprehensiveness, and directivity. Although the gene-guided protein synthesis often displays differences in the synthetic process and protein and cell analyses are usually required to confirm the results, the gene expression profile determined by genomic analysis may reflect the differentially expressed genes, and the functional analysis of these genes may determine global changes in a disease and present a direction to the understanding of the disease. The global analysis of genomics is superior to other tools. 1. Gene ontology analysis showed that the differentially expressed genes in PE patients reflected the downregulation of T cell immune receptor complexes and T cell-mediated immunity as compared to control group [17] . 2. In respect of innate immunity, the genes related to phagocytes, NK cells, complements, and cytokines were compared between PE patients and controls. (a) mRNA expression of phagocytes related genes: as compared to controls, the mRNA expression of pattern recognition receptor and conditioning receptors in phagocytes was significantly upregulated in PE patients, suggesting the enhancement of phagocyte function [18] . (b) mRNA expression of NK cell-related genes: when compared with control group, the mRNA expression of 7/10 of lectin-like receptors and natural cytotoxic effector receptors reduced significantly (P < 0.05), suggesting that the NK cell-mediated killing of target cells was significantly compromised [19] . (c) mRNA expression of genes related to complements: when compared with the control group, the mRNA expression of intrinsic ingredients of complements, receptors, and regulatory proteins was disordered, indicating the interrupted cascade reaction of complement system and the loss of complement-mediated membrane lysis [20] . (d) mRNA expression of genes related to cytokines: when compared with the control group, the mRNA expression of the following genes changed significantly in PE group. Interferon gene: mRNA expression of type I interferon reduced (P < 0.05), and IFN-γ mRNA expression decreased significantly (P < 0.01) in PE group [21] . Interleukin: mRNA expression of Th1-related genes to Th2-related genes reduced in PE group, suggesting reduced killing activity [21, 22] . Chemokines: mRNA expression of 12 CXC-related genes was significantly upregulated (P < 0.01) in PE group, and CXCL10 mRNA expression reduced markedly (P < 0.01); mRNA expression of 23 CC-related genes reduced dramatically in PE group (P < 0.01) [21] . Tumor necrosis factor: Thirty-eight genes encoding members of the TNF superfamily and TNF receptor superfamily were examined. In PE patients, the mRNA expression levels of TNF superfamily members 1, 9, and 13, and TNF receptor superfamily members 1A, 1B, 9, 10B, 10C, 10D, and 19L, were significantly upregulated (P < 0.05), whereas TNF receptor superfamily members 11B, 19, and 25 were significantly downregulated compared to the controls (P < 0.05) [20] . Colony stimulating factor: In PE group, the mRNA expression of CSF3, THPO, KITLG (P < 0.05), CSF2, and THPO (P < 0.01) changed significantly [21] . Other cytokines: In PE group, the mRNA expression of TGFB1, TGFB1I1, EGF, and VEGF increased markedly (P < 0.01), but TGF B3 mRNA expression reduced dramatically (P < 0.05) [21] . In PE patients, the mRNA expression of some cytokines was disordered, which reflects reduced killing activity against microorganisms, so the human body is susceptible to infection by virus, intracellular bacteria, and parasite [21] . (e) In PE group, the mRNA expression of some integrins related to leukocytes and platelets was significantly upregulated; mRNA expression of L-selectin and PSGL-1 increased significantly, but E-selectin mRNA expression reduced markedly; mRNA expression of typical cadherin and cadherin precursor showed reducing tendency, and mRNA expression of VE-cadherin reduced significantly; mRNA expression of immunoglobulin superfamily members remained unchanged. These findings indicate that the leukocyte adhesion is significantly enhanced; the platelet adhesion is markedly enhanced; the activity of endothelial cells is significantly compromised; the adhesion between endothelial cells is markedly compromised, leading to the increased endothelial permeability [23] . (f) Thirteen differentially expressed genes were leukocyte-related integrin genes. In PE group, mRNA expression of integrin β 1 and β 2 increased significantly (P < 0.05); platelet-related integrins (n = 7) displayed changed mRNA expression in PE group, of which the mRNA expression of integrin β 1 and β 3 increased significantly (P < 0.05); the mRNA expression of other ten integrins was either up-or downregulated. These imply that the mRNA expression of leukocyte-and platelet-related integrins is significantly upregulated, and the mRNA expression of fibronectin-and fibrinogen-related integrins also changed markedly [23] . 3. In respect of adaptive immunity, the expression of T cell-and B cell-related genes was compared between the PE and control groups. (a) T lymphocyte-related genes in PE group: of six genes related to the T lymphocyte immune synapses, receptor complex, cytoplasmic membrane, and receptors, the mRNA expression of ZAP70, CD247, GZMB (P < 0.05), GZMA, CD 3 G, and CD 3 D (P < 0.01) decreased dramatically [18] . (b) Genes related to B cells: a total of 82 differentially expressed genes were related to B cell activation. These genes included (1) B cell receptor-related genes (the mRNA expression of LYN, CD22, SYK (P < 0.05), BTK, PTPRC, and NFAM1 (P < 0.01) was significantly upregulated, but the mRNA expression of FYN (P < 0.05), FCRL4, and LAX1 (P < 0.01) was markedly downregulated in PE group), (2) T cell-dependent B cell activation-related genes (the mRNA expression of EMR2 (P < 0.05), TNFSF9, CD 8 6, ICOSLG, CD 3 7, and CD97 (P < 0.05) was significantly upregulated, but the SPN mRNA expression was markedly downregulated (P < 0.05)), and (3) T cell nondependent B cell activation-related genes (the mRNA expression of LILRA1 and TLR9 increased dramatically in PE patients (P < 0.01) [24] ). In PE group, the mRNA expression of CR1, LILRB4, and VAV1 was significantly upregulated (P < 0.01) but that of SLAMF7 reduced markedly (P < 0.01) [21] . 5. Genes of B cell-related cytokines: In PE group, the mRNA expression of LTA (P < 0.05) and IL-10 (P < 0.01) increased significantly but that of L1A, IFNA5, IFNA6, IFNA8, IFNA14 (P < 0.05), IL2, IL13, and IFNG (P < 0.01) reduced markedly. These indicate that there is B cell dysfunction in PE patients [24] . Phagocytes, NK cells, complement system, T cells, and B cells are the important components of innate and adaptive immune systems, and both of them play important roles in the defense against pathogens. These components together exert the defense effects. Results from genomic analysis indicate that the expression of phagocyte-related genes increases significantly but that of NK cell-related genes reduces markedly, the expression of complement-related genes is disordered but that of cytokine-related genes shows imbalance, and the expression of T cell-related genes reduces dramatically and that of B cell-related genes is disordered. These imply that the balance of systemic immune cell function collapses. In a family with familial VTE (Fig. 1.21a) , perforin gene mutation was found in three patients [25] . Perforin is localized in NK cells, T cells, and complement. Results showed the combined immune function (killing of target cells) was lost. NK cells, CD 8 + T cells, and complement form membrane attack complex to kill the target cells in which the perforin drills a hole in the target cells, leading to the release of granzymes and the death of these target cells. The mutation of the perforin gene may cause the generation of abnormal protein ( Fig. 1.21b) , resulting in loss of function. In patients with symptomatic PE, genomic analysis showed the mRNA expression of granzyme in T cells reduced significantly, suggesting the compromised killing activity of T cells. Although perforin and granzyme act at different steps of killing of target cells, the gene mutation of perforin in familial VTE patients and reduced mRNA expression of granzyme in patients with symptomatic PE cause the same consequence: compromised killing activity of immune cells [25] . Smeeth reported that the pathogenesis of VTE was related to infection, and the risk for VTE increased by 1.91-folds at 2 weeks to 6 months after acute respiratory tract infection [26] . Two large-scale case-control studies also revealed that acute infection could increase the risk for VTE by two-to threefolds after adjusting for other risk factors [27, 28] . In a patient who died of SARS, DVT was found in multiple organs including the pulmonary artery, kidney, liver, and pancreas, suggesting that viral infection is closely related to the pathogenesis of VTE (Fig. 1.22 ) [29] . A group of patients with acute PE showed significantly compromised function of CD 3 + and CD 8 + cells [30] ; a group of patients with CTEPH displayed markedly compromised function of CD 3 + and CD 8 + cells [31] ; a group of patients with acute symptomatic VTE presented reduced/disordered expression of CD 3 + , CD 8 + , CD 16 + ,CD 56 + , and CD 19 + , which was observed in 95% of these patients [32] . The results from cytological examination are consistent with those from genomic analysis and both indicate the compromised immune cell balance. T cells are the core component of immune cells. In T helper (Th) cells, Th1, Th2, and Th17 cells may regulate cellular, humoral, and innate immunity, respectively. The compromised T cell function may significantly reduce the systemic immune function. The collapse of immune cell balance function refers to the nonfunctional state or a state of significantly compromised function of immune cells. In VTE patients, cytological examination reveals that the T cell function is significantly compromised, and genomic analysis indicates that the function 3 II1 II2 II3 I1 I2 II4 II5 II6 II7 II8 II9 II10 III1 IVI III2 III3 III4 + of systemic immune cells is significantly inhibited. These suggest that the immune cells become dysfunctional and present a collapsed state of immune cell balance function. Malignancy is a risk factor of VTE, and VTE has been one of the main causes of death in malignant patients [33] [34] [35] . The risk for VTE in malignancy patients is 4-7 times higher than in subjects without malignancy [36] [37] [38] . The occurrence of malignancy is a consequence of ineffective and delayed clearance of malignant cells by immune cells. We reported that there were necrosis, granulation tissues and rupture of small veins on the sigmoid colon adenocarcinoma, and dark-staining fibrinogen in the vein formed filament-like mesh [13, 14] . In addition, in the necrotic area of poorly differentiated adenocarcinoma of the stomach, a large amount of red cells were observed outside the blood vessels ( Fig. 1.23 around the veins, and dark-staining fibrinogen formed filament-like mesh in which there were a large amount of cancer cells; the filament-like mesh was able to block the hematogenous metastasis of cancer cells. Based on these findings, we speculate that the occurrence of VTE and hemorrhage in malignancy patients is consequent to the invasion of cancer cells into surrounding veins and arteries due to the unlimited proliferation of cancer cells and is a product in the proliferative phase of cancer cells. A total of 1006 subjects were divided into VTE group, risk factor group, and control group, and flow cytometry was employed to detect the core proteins. In healthy controls, the normal range of integrins β 1 , β 2 , and β 3 expression was determined [39] . When compared with control group, the integrin β 1 expression increased significantly in VTE group and INF [acute infection], CAN [cancer] , and IMD [autoimmune disease] of risk factor group (P < 0.001, P < 0.01) but not on surgery and trauma subgroups (SUR) of risk factor group (P > 0.05). When compared with control group, the integrin β 2 expression increased significantly in VTE group but not in INF, CAN, IMD, surgery, and trauma (SUR) subgroups (P > 0.05) of risk factor group. When compared with control group, the integrin β 3 expression increased significantly in VTE group but not in INF, CAN, IMD, surgery, and trauma (SUR) subgroups (P > 0.05) of risk factor group ( Fig. 1.24) . When compared with control group, the integrins β 1 , β 2 , and β 3 expression increased significantly in VTE group; the integrin β 1 expression in INF, CAN, and IMD subgroups of risk factor group was significantly higher than in control group; the integrins β 1 , β 2 , and β 3 expression in surgery and trauma subgroup (SUR) was comparable to that in control group (P > 0.05). These results showed integrin β 1 is a shared protein between VTE group and risk factor group, and the increase in integrins β 2 and β 3 is a key in the occurrence of VTE; the increase in integrin β 1 is a characteristic of risk factor group, but it remains unchanged in surgery and trauma (SUR) subgroup, which has no increased expression of core protein as in other subgroups of risk factor group. Thus, we propose that surgery and trauma themselves are not the true risk factors of VTE, but the occurrence of VTE in patients with trauma or surgery is temporally consistent with the presence of collapse of immune cell balancing function. We investigated the efficacy of integrins β 1 , β 2 , and β 3 expression in the diagnosis of VTE in 120 patients. Our results showed the area under the ROC was 0.870, 0.821, and 0.731 for integrins β 1 , β 2 , and β 3 , respectively, in the diagnosis of acute VTE; the ideal threshold of Youden index was 10 with intracellular infection/malignant cells. Advanced age, infection, trauma, surgery, autoimmune disease, pregnancy, delivery, long distance travel syndrome, and family history are the risk factors of VTE. In the presence of collapse of immune cell balance function, venous thrombosis may occur in the subjects with these risk factors. In subjects with normal immune cell balance function, intracellular infection/proliferation of cancer cells usually does not cause VTE even in the presence of risk factors. The core proteins of acute venous thrombus are the integrins β 1 , β 2 , and β 3 , and increase in these proteins was observed in VTE patients. The increase in integrin β 1 alone was a characteristic of patients with risk factors for VTE. The clinical detection of integrins β 1 , β 2 , and β 3 may guide the diagnosis of VTE, the anticoagulation treatment, and the screening of population with risk for VTE [41] [42] . European Venous Forum; North American Thrombosis Forum; International Union of Angiology; Union Internationale du Phlebologie. Prevention and treatment of venous thromboembolism. International Con sensus Statement (guidelines according to scientific evidence) Physician alerts to prevent venous thromboembolism American College of Chest Physicians Evidence-Based Clinical Practice Guidelines A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis Confusion of wide thrombolytic time window for acute pulmonary embolism: mass spectrographic analysis for thrombus proteins Integrin signaling The integrins Crystal structure of the extracellular segment of integrin alpha Vbeta3 Integrin structure Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2 Expression of alpha v and beta 3 integrin chains on murine lymphocytes Differences of alpha3beta1 integrin glycans from different human bladder cell lines Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis Venous thromboembolism is a product in proliferation of cancer cells Compromised T-cell immunity and virus-like structure in a patient with pulmonary hypertension Rod-like bacteria and recurrent venous thromboembolism Analysis of the protein-protein interaction networks of differentially expressed genes in pulmonary embolism Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics Compromised natural killer cells in pulmonary embolism Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism Gene expression levels of cytokines in peripheral blood mononuclear cells from patients with pulmonary embolism mRNA expression of interleukins and Th1/Th2 imbalance in patients with pulmonary embolism Genomic characteristics of adhesion molecules in patients with symptomatic pulmonary embolism Expression of B cell related genes in peripheral blood mononuclear cells of patients with symptomatic pulmonary embolism Characterization of immune cell/molecule perforin mutations in a family with venous thromboembolism Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database Acute infections and venous thromboembolism Severe acute respiratory syndrome and venous thromboembolism in multiple organs Acute pulmonary embolism and dysfunction of CD 3 + CD 8 + T cell immunity T cell-mediated immune deficiency or compromise in patients with CTEPH Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction Incidence of venous thromboembolism and its effect on survival among patients with common cancers The risk of venous thromboembolism in patients with cancer Incidence of venous thromboembolism and the impact on survival in breast cancer patients Epidemiology of cancer-related venous thromboembolism Malignancies, pro-thrombotic mutations, and the risk of venous thrombosis Venous thromboembolism is a product in proliferation of cancer cells Internal relationship between symptomatic venous thromboembolism and risk factors: upregulation of integrin β 1 , β 2 and β 3 levels Increased expressions of integrin subunit beta1, beta2 and beta3 in patients with venous thromboembolism: new markers for venous thromboembolism Early diagnosis of venous thromboembolism as a clinical primary symptom of occult cancer:Core proteins of a venous thrombus The origin and onset of acute venous thrombus